Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysis

Since the COVID‐19 pandemic, physicians concerned about the potential adverse effects of angiotensin converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs). To explore the relationship between ACEIs/ARBs and the risk of mortality and other clinical outcomes in COVID‐19 patients, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Na, Zhang, Guifang, Sun, Xuelin, Wang, Yan, Zhao, Sai, Chi, Wenjie, Dong, Sitong, Xia, Jun, Zeng, Ping, Liu, Deping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review and Meta‐analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420264/
https://www.ncbi.nlm.nih.gov/pubmed/34320275
http://dx.doi.org/10.1111/jch.14329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420264/
https://www.ncbi.nlm.nih.gov/pubmed/34320275
http://dx.doi.org/10.1111/jch.14329

Ejemplares similares